Results 91 to 100 of about 5,159 (186)
CBD for CLN2 disease [dataset]
This dataset provides supporting data for the manuscript titled "Chronic oral cannabidiol delays or prevents seizures in a mouse model of CLN2 disease" and is deposited to comply with PLOS One data availability requirements.
Jian, Xing
core +1 more source
The neuronal ceroid lipofuscinosis type 2 (CLN2) is a heterogeneous group of neurodegenerative lysosomal storage disorders caused by autosomal recessive inheritance of two pathogenic variants in trans in the TPP1 gene.
Nataliia Olkhovych +11 more
doaj +1 more source
Appressoria are specialized penetration structures for many plant pathogenic fungi, demanding precise cell cycle control. This study unveils MoMtg1 as a transcriptional repressor of MoSwi6, orchestrating MoCYC1 expression during turgor‐driven cell cycle progression to enable appressorium‐mediated penetration. Moreover, a small‐molecule inhibitor ZS1619
Xingyu Wang +11 more
wiley +1 more source
Trial Readiness: Understanding the Natural History of Rare Diseases
ABSTRACT Inherited metabolic diseases (IMD) represent the largest and still growing group of treatable genetic disorders and are increasingly amenable to targeted interventions that achieve varying degrees of prognostic improvement. Innovative therapies are on the horizon and offer promising opportunities for disease‐changing treatment for a variety of
Thomas Opladen +6 more
wiley +1 more source
SIT4 protein phosphatase is required for the normal accumulation of SWI4, CLN1, CLN2, and HCS26 RNAs during late G1 [PDF]
In Saccharomyces cerevisiae, the RNA levels of the G1 cyclins CLN1, CLN2, and HCS26 increase dramatically during the late G1 phase of the cell cycle.
Zhong, T. +7 more
core +1 more source
Proteins at the CLN2 promoter.
(A) Map of the CLN2 promoter, showing the location of the up, sbf, and dwn probes in the BBP1-CLN2 intergenic region. The sbf probe overlaps the consensus SBF binding sites. The dyn probe is in the middle of the DYN1 open reading frame, several kilobases
Herman Wijnen (61991) +4 more
core +1 more source
To elucidate the mechanisms underlying adriamycin resistance, adriamycin resistance-related genes were explored using the budding yeast Saccharomyces cerevisiae as a useful eukaryotic model. The CLN1 and CLN2 genes, encoding G1 cyclin, and the ERG13 gene, encoding 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) synthase, were identified.
Takahashi, Tsutomu +5 more
openaire +3 more sources
Positive feedback in CLN2 activation and the coherence of entry into Start.
A and B. Joint distributions of the times from birth to the activation of the genes for RAD27 (Tbir,RAD27) and CLN2 (Tbir,CLN2) are plotted for WT and cln1Δcln2Δ cells from single-cycle simulations for an extant population of 500 mother (blue) and 500 ...
Jean Peccoud (142023) +3 more
core +1 more source
Flupirtine derivatives as potential treatment for the neuronal ceroid lipofuscinoses
Objective Neuronal Ceroid Lipofuscinoses (NCL) are fatal inherited neurodegenerative diseases with established neuronal cell death and increased ceramide levels in brain, hence, a need for disease‐modifying drug candidates, with potential to enhance ...
Joelle Makoukji +7 more
doaj +1 more source
FDA orphan drug designations for lysosomal storage disorders - a cross-sectional analysis.
PurposeTo provide a quantitative clinical-regulatory insight into the status of FDA orphan drug designations for compounds intended to treat lysosomal storage disorders (LSDs).MethodsAssessment of the drug pipeline through analysis of the FDA database ...
Sven F Garbade +7 more
doaj +1 more source

